Across TCGA pan-cancer cohorts, LINC01729 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of LINC01729’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC01729 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01729 is over-expressed in tumor, although a few such as PAAD and LUSC show the opposite, repressed pattern.

KIRC, PAAD, and HNSC are the cancer types where LINC01729 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01729 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	II,III,IV	+0.023	.025	4	view →
PAAD	Female	All	−0.260	.049	2	view →
HNSC	All	All	+0.043	.032	2	view →
LUSC	All	III,IV	−0.216	.037	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: LINC01729 RNA expression & survival · all LINC01729 data types